Stocks Health care LNAI

NASDAQ · Health care

Lunai Bioworks Inc. (LNAI)

It posted a net loss of $128.3M. At March 31, 2026 it held $3.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 15, 2026.

What Lunai Bioworks Inc. does

Lunai Bioworks Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker LNAI.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Lunai Bioworks Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. July 17, 2026
   Passive stake (5% or more) SCHEDULE 13G
2. June 17, 2026
   Other event 8-K
3. June 16, 2026
   Other event 8-K
4. May 20, 2026
   Other event 8-K
5. May 15, 2026
   Quarterly report 10-Q · period to March 31, 2026Revenue was $20.9K; diluted EPS -$0.10 versus $0.00.
6. May 13, 2026
   Shareholder vote results 8-K
7. May 11, 2026
   Stock exchange listing notice 8-K/A
8. May 1, 2026
   Form DEFR14A filing DEFR14A
9. May 1, 2026
   Acquisition or sale completed 8-K
10. April 28, 2026
    Other event 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on March 12, 2025. Insider transactions on SEC

Who owns LNAI

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about LNAI

What does Lunai Bioworks Inc. do?

Lunai Bioworks Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker LNAI.

Is Lunai Bioworks Inc. profitable?

No. Over the twelve months to March 31, 2026 it reported a net loss of $128.3M.

When did Lunai Bioworks Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on May 15, 2026. It covers the period to March 31, 2026. Its newest filing of any kind is the passive stake (5% or more) from July 17, 2026.

Similar companies

Compare LNAI with

Compare LNAI with any company

Follow LNAI

Get an email when Lunai Bioworks Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow LNAI: get an email when it files

Where the numbers come from

Financial figures are the values Lunai Bioworks Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.